Skip to main content
. 2024 Mar 10;14(1):e12351. doi: 10.1002/pul2.12351

Figure 1.

Figure 1

Comparison of clinical parameters before and after 6 months of treatment in the entire cohort. (a) WHO functional class (WHO‐FC); (b) 6‐min walk distance (6MWD); (c) N‐terminal fragment of probrain natriuretic peptide (NT‐proBNP); (d) The number of low risk criteria. WHO, World Health Organization.